Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Anticancer Research
|
November 1, 1992
Expression of HER-2/neu oncoprotein in human breast cancer: a comparison of immunohistochemical and western blot techniques
R Molina, D R Ciocca, A K Tandon, et al.
Breast Cancer Research and Treatment
|
June 28, 2005
Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIalpha for anthracycline chemotherapy in locally advanced breast cancer
G Arpino, D R Ciocca, H Weiss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1994
Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer
P M Ravdin, A K Tandon, D C Allred, et al.
Human Pathology
|
September 1, 1992
Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer
D C Allred, G M Clark, R Molina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study
R M Elledge, S Green, D Ciocca, et al.
Breast Cancer Research and Treatment
|
January 1, 1993
The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain
S A Fuqua, D C Allred, R M Elledge, et al.
Cancer Research
|
January 15, 1992
Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors
S A Fuqua, S D Fitzgerald, D C Allred, et al.
Cancer Research
|
August 17, 2000
A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions
S A Fuqua, C Wiltschke, Q X Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1992
HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma
D C Allred, G M Clark, A K Tandon, et al.
Virchows Archiv : an International Journal of Pathology
|
January 1, 1994
p53 mutations in gastric and colorectal cancers in Texas Hispanics versus Anglos
B G Schneider, S G Hilsenbeck, C H Hensel, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Anticancer Research
|
November 1, 1992
Expression of HER-2/neu oncoprotein in human breast cancer: a comparison of immunohistochemical and western blot techniques
R Molina, D R Ciocca, A K Tandon, et al.
Breast Cancer Research and Treatment
|
June 28, 2005
Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIalpha for anthracycline chemotherapy in locally advanced breast cancer
G Arpino, D R Ciocca, H Weiss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1994
Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer
P M Ravdin, A K Tandon, D C Allred, et al.
Human Pathology
|
September 1, 1992
Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer
D C Allred, G M Clark, R Molina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study
R M Elledge, S Green, D Ciocca, et al.
Breast Cancer Research and Treatment
|
January 1, 1993
The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain
S A Fuqua, D C Allred, R M Elledge, et al.
Cancer Research
|
January 15, 1992
Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors
S A Fuqua, S D Fitzgerald, D C Allred, et al.
Cancer Research
|
August 17, 2000
A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions
S A Fuqua, C Wiltschke, Q X Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1992
HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma
D C Allred, G M Clark, A K Tandon, et al.
Virchows Archiv : an International Journal of Pathology
|
January 1, 1994
p53 mutations in gastric and colorectal cancers in Texas Hispanics versus Anglos
B G Schneider, S G Hilsenbeck, C H Hensel, et al.
Page
of 8